AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
84 hedge funds and large institutions have $268M invested in Akcea Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 11 closing their positions.
Holders
84
Holders Change
+7
Holders Change %
+9.09%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
38
Reduced
18
Closed
11
Calls
$1.3M
Puts
$1.45M
Net Calls
-$156K
Net Calls Change
+$217K
Top Buyers
| 1 |
1
BlackRock
New York
|
$31.5M |
| 2 |
2
Renaissance Technologies
New York
|
$4.12M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$3.53M |
| 4 |
4
D.E. Shaw & Co
New York
|
$6.08M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$20.1M |
